Latest filing published 15 May 2008 for MILLENNIUM PHARMACEUTICALS INC, €1.2M.
No signal scores available.
All filings by Peter Smith on record concern Millennium Pharmaceuticals Inc. We count 6 filings; the first trade dates from 30 July 2007 and the latest from 14 May 2008.
The open-market record consists of 2 sales worth €135k, with no purchase. Other entries cover 2 share grants. 2008 to date brings no purchases and 1 sale.
On 15 May 2008 came the latest disclosure, a transaction for €1.2M in Millennium Pharmaceuticals Inc. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations